Cart (0 Items)
Your cart is currently empty.
View ProductsOzanezumab Biosimilar – Anti-RTN4, NOGO mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1-nd |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Ozanezumab Biosimilar - Anti-RTN4, NOGO mAb - Research Grade |
|---|---|
| Source | CAS 1310680-64-8 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Ozanezumab,GSK-1223249,RTN4, NOGO,anti-RTN4, NOGO |
| Reference | PX-TA1313 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-nd |
| Clonality | Monoclonal Antibody |
Description of Ozanezumab Biosimilar - Anti-RTN4, NOGO mAb - Research Grade
General information on Anti-RTN4/NOGO[Homo sapiens] (Ozanezumab) Monoclonal Antibody
Ozanezumab has been investigated for the treatment of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis, Relapsing-Remitting.
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.